Stockscreener 앱 받기
0.7629
10.12%
-0.0859
시간 외 거래:
.76
-0.0029
-0.38%
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Contrasting Inhibikase Therapeutics (NASDAQ:IKT) & Liminatus Pharma (NASDAQ:LIMN) - Defense World
Investment Recap: Will Liminatus Pharma Inc stock benefit from AI adoptionPrice Action & AI Forecasted Entry and Exit Points - moha.gov.vn
Will Liminatus Pharma Inc. stock reach Wall Street targetsPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
What sentiment indicators say about Liminatus Pharma Inc. Equity Warrant stockEarnings Trend Report & Real-Time Buy Signal Alerts - Newser
Is Liminatus Pharma Inc. stock trading at a premium valuationTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Chart Watch: Can TriCo Bancshares stock beat market expectations this quarterCPI Data & Daily Volume Surge Signals - BỘ NỘI VỤ
Reviewing Vor Biopharma (NASDAQ:VOR) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Will Liminatus Pharma Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Gains Summary & Risk Controlled Daily Plans - moha.gov.vn
Can Liminatus Pharma Inc. stock outperform in 2025 bull marketEarnings Risk Report & Growth Focused Entry Reports - moha.gov.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Liminatus Pharma Faces Nasdaq Non-Compliance Notice - MSN
Is Liminatus Pharma Inc. stock in correction or buying zoneJuly 2025 Short Interest & Safe Entry Momentum Tips - moha.gov.vn
Liminatus Pharma receives Nasdaq notice for non-compliance with listing standards - Investing.com
LIMN gets Nasdaq warnings over market value and listing rules - Stock Titan
Holdings of Chegg Inc (CHGG) are aligned with the stars - Setenews
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Views of Wall Street’s Leading Experts on Liminatus Pharma Inc - Setenews
Published on: 2025-11-24 07:40:26 - earlytimes.in
What analysts say about Liminatus Pharma Inc Equity Warrant stockTechnology Stock Trends & Free Get High Impact Recommendations - earlytimes.in
Liminatus Pharma (NASDAQ:LIMN) versus Prime Medicine (NASDAQ:PRME) Head to Head Comparison - Defense World
Liminatus Pharma (NASDAQ:LIMN) Downgraded by Wall Street Zen to Strong Sell - Defense World
Midday Stock Roundup: RxSight up 14% - Orange County Business Journal
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Liminatus Pharma, Inc. Class A Common Stock (LIMN) -29.6% in Normal Trading: Significant Drop Amid Routine Trading - Stocks Telegraph
Dow Surges Over 200 Points; BJ's Wholesale Posts Upbeat Q3 Earnings - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Liminatus Pharma Inc. Equity Warrant stock a defensive play in 2025Earnings Miss & Low Drawdown Trading Techniques - newser.com
Why Liminatus Pharma Inc. Equity Warrant stock attracts high net worth investorsPortfolio Update Report & Reliable Price Breakout Alerts - newser.com
Prime Medicine (NASDAQ:PRME) and Liminatus Pharma (NASDAQ:LIMN) Critical Review - Defense World
Is Liminatus Pharma Inc. stock recession proof2025 Buyback Activity & Fast Gain Swing Alerts - newser.com
Signal strength of Liminatus Pharma Inc. stock in tech scannersJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock deliver strong dividend growthJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
Why Liminatus Pharma Inc. Equity Warrant stock is seen as undervaluedQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Backtesting results for Liminatus Pharma Inc. trading strategies2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
How to use Fibonacci retracement on Liminatus Pharma Inc. Equity WarrantMarket Performance Summary & Capital Protection Trade Alerts - newser.com
Is Liminatus Pharma Inc. Equity Warrant forming a bottoming baseQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Multi factor analysis applied to Liminatus Pharma Inc.July 2025 Gainers & Weekly Sector Rotation Insights - newser.com
Is Liminatus Pharma Inc. stock entering bullish territoryJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
What risks investors should watch in Liminatus Pharma Inc. Equity Warrant stock2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
Analyzing recovery setups for Liminatus Pharma Inc. Equity Warrant investors2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
[At the Crossroads] Ewha Compotech ④ Unable to Receive Liminatus Shares for 6 Months... Only Suspicious Funds Reaped Gains - 아시아경제
Contrasting Prime Medicine (NASDAQ:PRME) & Liminatus Pharma (NASDAQ:LIMN) - Defense World
Analyzing Prime Medicine (NASDAQ:PRME) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Is Liminatus Pharma Inc. showing signs of accumulationIndex Update & Weekly Top Stock Performers List - newser.com
[At a Crossroads] Ewha Compotech③ Capital Erosion Begins Amid 'Liminatus Pharma' Losses - 아시아경제
Using data models to predict Liminatus Pharma Inc. Equity Warrant stock movementWeekly Gains Report & Entry Point Strategy Guides - newser.com
0.36%
1.05%
자본화:
|
볼륨(24시간):